One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

New research suggests that receiving multiple doses of a vaccine in the same limb leads to faster antibody development, an ...

As sales of its COVID vaccine plummet, Novavax is looking ahead toward other novel vaccines, brought to market with the help ...

Department of Health and Human Services Secretary Robert F. Kennedy Jr. paused a $240 million contract to create a new coronavirus vaccine.

This page is no longer being updated and reflects the status of vaccine progress through March 4, 2021. For more coverage about the pandemic, visit our coronavirus hub. 3 vaccineshave been ...

Triumphs of COVID-19 included rapid vaccine development and scientific collaboration. But the tragedies were numerous.

Emergent BioSolutions is investing in Swiss biotech Rocketvax, inking a deal designed to fuel the preclinical company’s R&D.

Studies have suggested COVID-19 vaccines, combined with mitigation measures, helped save hundreds of thousands of lives in the U.S. Weekly COVID-19 Deaths in the U.S. Long COVID is a condition ...

Anti-vaccine sentiment is on the rise in the U.S., influenced by the COVID-19 pandemic. Measles outbreaks are occurring, particularly among unvaccinated children, and flu cases are surging nationwide.

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...